Adrenocortical Carcinoma Clinical Trials

• Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer
  ClinicalTrials.gov Identifier: NCT00002921 - Active, not recruiting
  Adrenocortical Carcinoma
  
• Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
  ClinicalTrials.gov Identifier: NCT00003453 - Recruiting
  stage IV adrenocortical carcinoma; recurrent adrenocortical carcinoma
  
• Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)
  ClinicalTrials.gov Identifier: NCT00215202 - Active, not recruiting
  Nonresectable Adrenocortical Carcinoma
  
• Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma
  ClinicalTrials.gov Identifier: NCT00457587 - Recruiting
  Adrenocortical Carcinoma; Cushing's Syndrome
  
• Trial With Taxotere and Cisplatin in Non-Operable Adrenocortical Carcinoma
  ClinicalTrials.gov Identifier: NCT00324012 - Recruiting
  Adrenocortical Carcinoma
  
• Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma
  ClinicalTrials.gov Identifier: NCT00469469 - Recruiting
  Adrenocortical Carcinoma
  
• Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
  ClinicalTrials.gov Identifier: NCT00304070 - Recruiting
  Adrenocortical Carcinoma
  
• German Adrenocortical Carcinoma Registry
  ClinicalTrials.gov Identifier: NCT00453674 - Recruiting
  Adrenocortical Carcinoma
  
• Sunitinib in Refractory Adrenocortical Carcinoma
  ClinicalTrials.gov Identifier: NCT00453895 - Recruiting
  Adrenocortical Carcinoma
  
• Tariquidar, Mitotane, Doxorubicin, Vincristine, and Etoposide Plus Surgery in Treating Patients With Recurrent, Metastatic, or Primary Unresectable Adrenocortical Cancer
  ClinicalTrials.gov Identifier: NCT00073996 - Recruiting
  Adrenocortical Carcinoma
  
• Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)
  ClinicalTrials.gov Identifier: NCT00094497 - Recruiting
  Carcinoma, Adrenal Cortical
  
• Evaluation of Side Effects of Mitotane
  ClinicalTrials.gov Identifier: NCT00568139 - Not yet recruiting
  Adrenocortical Carcinoma
  
• Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging
  ClinicalTrials.gov Identifier: NCT00445718 - Recruiting
  Adrenocortical Carcinoma; Neuroblastoma; Precancerous/Nonmalignant Condition
  
• Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy
  ClinicalTrials.gov Identifier: NCT00454103 - Recruiting
  Adrenal Tumor; Adrenocortical Carcinoma
  
• Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00436410 - Recruiting
  Adrenocortical Carcinoma; Breast Cancer; Colorectal Cancer; Kidney Cancer; Liver Cancer; Melanoma (Skin); Ovarian Cancer; Pancreatic Cancer
  
• A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide with Daily Mitotane Before and After Surgical Resection
  ClinicalTrials.gov Identifier: NCT00001339 - Completed
  Adrenal Cortical Carcinoma
  
• Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Abdominal Cancer
  ClinicalTrials.gov Identifier: NCT00436657 - Recruiting
  Peritoneal Neoplasms; Retroperitoneal Neoplasms; Gastrointestinal Neoplasms; Adenocarcinoma; Neuroblastoma; Ovarian Neoplasms; Sarcoma; Adrenocortical Carcinoma; Wilms Tumor; Rhabdomyosarcoma; Desmoplastic Small Round Cell Tumor
  
• Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002659 - Active, not recruiting
  recurrent squamous cell carcinoma of the hypopharynx; recurrent squamous cell carcinoma of the larynx; ...
  
• Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003257 - Active, not recruiting
  recurrent squamous cell carcinoma of the hypopharynx; recurrent squamous cell carcinoma of the larynx; ...
  
• Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma
  ClinicalTrials.gov Identifier: NCT00165126 - Active, not recruiting
  Endometrial Carcinoma; Cervix Cancer; Carcinoma of the Uterus
  
• Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin
  ClinicalTrials.gov Identifier: NCT00022178 - Active, not recruiting
  squamous cell carcinoma of unknown primary; newly diagnosed carcinoma of unknown primary; undifferentiated carcinoma of unknown primary; ...
  
• A Research Study to Treat Patients with Advanced Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00105443 - Active, not recruiting
  Hepatocellular Carcinoma
  
• Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00003856 - Active, not recruiting
  recurrent squamous cell carcinoma of the oropharynx; recurrent squamous cell carcinoma of the hypopharynx; recurrent salivary gland cancer; ...
  
• Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
  ClinicalTrials.gov Identifier: NCT00002506 - Active, not recruiting
  recurrent non-small cell lung cancer; recurrent cervical cancer; recurrent squamous cell carcinoma of the lip and oral cavity; ...
  
• Patupilone Activity in Advanced/Metastatic Hepatocelluar Carcinoma
  ClinicalTrials.gov Identifier: NCT00273312 - Active, not recruiting
  Hepatocellular Carcinoma
  
• Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004246 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage IVA squamous cell carcinoma of the nasopharynx; ...
  
• RAD001 plus Depot Octreotide in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma
  ClinicalTrials.gov Identifier: NCT00113360 - Active, not recruiting
  Carcinoma, Neuroendocrine; Carcinoid Tumor; Carcinoma, Islet Cell
  
• Cetuximab in Patients with Unresectable or Metastatic Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00142428 - Active, not recruiting
  Unresectable hepatocellular carcinoma; Metastatic hepatocellular carcinoma; Hepatocellular Carcinoma
  
• Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00002670 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity; ...
  
• High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002555 - Active, not recruiting
  stage III squamous cell carcinoma of the lip and oral cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• ZD6474 With Radiation or Concomitantly With Weekly Cisplatin and Radiation Therapy, Stage III-IV Head and Neck Squamous Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00411710 - Recruiting
  Head and Neck Squamous Cell Carcinoma; Squamous Cell Carcinoma of the Oral Cavity; Squamous Cell Carcinoma of the Oropharynx; Squamous Cell Carcinoma of the Hypopharynx; Squamous Cell Carcinoma of the Larynx
  
• A Study of Motexafin Gadolinium (MGd) in Combination with Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00102505 - Active, not recruiting
  Non-Small-Cell Lung Carcinoma; Carcinoma, Bronchogenic
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00054054 - Active, not recruiting
  stage III squamous cell carcinoma of the hypopharynx; stage III squamous cell carcinoma of the larynx; ...
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003888 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage III squamous cell carcinoma of the hypopharynx; ...
  
• Phase 2b Study of VELCADE Alone and VELCADE plus Irinotecan in Patients with Relapsed or Refractory Colorectal Carcinoma
  ClinicalTrials.gov Identifier: NCT00051987 - Active, not recruiting
  Colorectal Carcinoma
  
• A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers
  ClinicalTrials.gov Identifier: NCT00122239 - Recruiting
  -breast carcinoma; -glioma; -prostate carcinoma; -squamous cell carcinoma of the head and neck; -lung carcinoma (non-small cell)
  
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00005814 - Active, not recruiting
  stage III squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; ...
  
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00113399 - Active, not recruiting
  recurrent squamous cell carcinoma of the hypopharynx; recurrent squamous cell carcinoma of the larynx; ...
  
• Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002654 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage III squamous cell carcinoma of the hypopharynx; ...
  
• Study of T900607-sodium in chemotherapy naive patients with hepatocellular carcinoma.
  ClinicalTrials.gov Identifier: NCT00043433 - Active, not recruiting
  Hepatocellular Carcinoma
  
• Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00004226 - Active, not recruiting
  recurrent squamous cell carcinoma of the lip and oral cavity; recurrent squamous cell carcinoma of the hypopharynx; ...
  
• Capecitabine in Treating Patients With Locally Recurrent or Metastatic Nasopharygeal Cancer
  ClinicalTrials.gov Identifier: NCT00095901 - Active, not recruiting
  recurrent squamous cell carcinoma of the nasopharynx; stage IV squamous cell carcinoma of the nasopharynx; ...
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004094 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage IV squamous cell carcinoma of the nasopharynx; ...
  
• Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00002932 - Active, not recruiting
  stage IV squamous cell carcinoma of the larynx; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00011999 - Active, not recruiting
  stage III squamous cell carcinoma of the lip and oral cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced or Regional Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00096174 - Active, not recruiting
  stage IV squamous cell carcinoma of the hypopharynx; stage IV squamous cell carcinoma of the larynx; ...
  
• Combination Chemotherapy and Radiation Therapy In Treating Patients With Stage III or Stage IV Cancer of the Hypopharynx or Tongue
  ClinicalTrials.gov Identifier: NCT00002735 - Active, not recruiting
  stage III squamous cell carcinoma of the hypopharynx; stage III squamous cell carcinoma of the oropharynx; ...
  
• Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00002493 - Active, not recruiting
  stage III endometrial cancer; stage IV endometrial cancer; endometrial clear cell carcinoma; endometrial adenosquamous cell carcinoma; ...
  
• Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003592 - Active, not recruiting
  stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• SU011248 in the Treatment of Patients with Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00089648 - Active, not recruiting
  Renal Cell Carcinoma
  
• Effect of Etomidate on Hemodynamics and Adrenocortical Function After Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00415701 - Recruiting
  Coronary Artery Disease; Mitral Valve Regurgitation
  
• Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA
  ClinicalTrials.gov Identifier: NCT00006431 - Active, not recruiting
  Renal Cell Carcinoma
  
• Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003328 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage III squamous cell carcinoma of the hypopharynx; ...
  
• SU011248 in the Treatment of Patients with Cytokine-Refractory Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00077974 - Active, not recruiting
  Renal Cell Carcinoma
  
• Treatment Protocol for the use of Sorafenib in Patients with Advanced Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00111020 - Active, not recruiting
  Renal Cell Carcinoma
  
• A Study to Estimate Safety and Efficacy of Bay 43-9006 in the Treatment of Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00044512 - Active, not recruiting
  Carcinoma, Hepatocellular
  
• Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00003200 - Active, not recruiting
  stage III squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; ...
  
• Gemcitabine, Docetaxel, and Capecitabine in Treating Patients with Cancer of Unknown Primary Origin
  ClinicalTrials.gov Identifier: NCT00119314 - Active, not recruiting
  newly diagnosed carcinoma of unknown primary; recurrent carcinoma of unknown primary
  
• Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients with Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00082459 - Active, not recruiting
  Renal Cell Carcinoma
  
• Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary
  ClinicalTrials.gov Identifier: NCT00066781 - Active, not recruiting
  adenocarcinoma of unknown primary; newly diagnosed carcinoma of unknown primary; squamous cell carcinoma of unknown primary; ...
  
• Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx
  ClinicalTrials.gov Identifier: NCT00002839 - Active, not recruiting
  stage II squamous cell carcinoma of the hypopharynx; stage III squamous cell carcinoma of the hypopharynx; ...
  
• Optical Biopsy of Human Skin in Conjunction With Laser Treatment
  ClinicalTrials.gov Identifier: NCT00540566 - Enrolling by invitation
  Malignant Melanoma,; Merkel Cell Carcinoma,; Basal Cell Carcinoma,; Squamous Cell Carcinoma; Atypical Nevi,; Congenital Nevi; Seborrheic Keratosis,; Paget's Disease; Dermatofibroma,; Kaposi's Sarcoma; Hypervascular Congenital Malformations; Port Wine Stain; Hemangioma; Tattoos; Scleroderma; Burns; Normal Skin
  
• Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer
  ClinicalTrials.gov Identifier: NCT00049166 - Active, not recruiting
  stage II squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the oropharynx; ...
  
• Using the Bioelectric Field Imager for Diagnosing Skin Cancer
  ClinicalTrials.gov Identifier: NCT00391300 - Active, not recruiting
  Basal Cell Carcinoma; Squamous Cell Carcinoma; Melanoma
  
• Low-Dose IL-2 Plus IFN-Alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma.
  ClinicalTrials.gov Identifier: NCT00502034 - Active, not recruiting
  Carcinoma, Renal Cell
  
• Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)
  ClinicalTrials.gov Identifier: NCT00563927 - Active, not recruiting
  Nasopharyngeal Neoplasms; Carcinoma, Squamous Cell
  
• Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
  ClinicalTrials.gov Identifier: NCT00047125 - Active, not recruiting
  newly diagnosed carcinoma of unknown primary; squamous cell carcinoma of unknown primary
  
• Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s)
  ClinicalTrials.gov Identifier: NCT00341146 - Active, not recruiting
  Nasopharyngeal Carcinoma
  
• Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00570674 - Recruiting
  Squamous Cell Carcinoma of the Head and Neck; Basaloid Squamous Cell Carcinoma; Undifferentiated Carcinoma; Adenosquamous Cell Carcinoma
  
• A Randomized, Placebo-Controlled, Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00165633 - Active, not recruiting
  : Hepatocellular, Carcinoma
  
• Evaluation of Breast Cancer Recurrence Rates Following Surgery for Ductal Carcinoma In Situ
  ClinicalTrials.gov Identifier: NCT00002934 - Active, not recruiting
  Breast Neoplasms; Carcinoma, Infiltrating Duct
  
• Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma
  ClinicalTrials.gov Identifier: NCT00314873 - Active, not recruiting
  Thymic Carcinoma
  
• Laser Surgery Plus Radiation Therapy in Treating Patients With Early Stage Cancer of the Larynx
  ClinicalTrials.gov Identifier: NCT00003040 - Active, not recruiting
  stage II squamous cell carcinoma of the larynx; stage III squamous cell carcinoma of the larynx; stage I squamous cell carcinoma of the larynx
  
• Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
  ClinicalTrials.gov Identifier: NCT00568906 - Recruiting
  Carcinoma, Giant Cell; Carcinoma, Non-Small-Cell Lung
  
• Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx
  ClinicalTrials.gov Identifier: NCT00002496 - Active, not recruiting
  stage III squamous cell carcinoma of the larynx; stage IV squamous cell carcinoma of the larynx
  
• Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00003514 - Recruiting
  Merkel Cell Carcinoma; Islet Cell Carcinoma; Neuroendocrine Carcinoma; Pituitary Tumor
  
• Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx
  ClinicalTrials.gov Identifier: NCT00003627 - Active, not recruiting
  stage III squamous cell carcinoma of the hypopharynx; stage III squamous cell carcinoma of the oropharynx; ...
  
• SU011248 versus Interferon-alfa as First-Line Systemic Therapy for Patients with Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00083889 - Active, not recruiting
  Renal Cell Carcinoma
  
• Trial Comparing Cisplatin With or Without Gemcitabine in Patients with Carcinoma of Unknown Primary
  ClinicalTrials.gov Identifier: NCT00126269 - Recruiting
  Carcinoma
  
• Panitumumab Plus Chemoradiotherapy and Induction Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00513383 - Recruiting
  Squamous Cell Carcinoma of the Head and Neck; Basaloid Squamous Cell Carcinoma; Undifferentiated Carcinoma; Adenosquamous Cell Carcinoma
  
• Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer
  ClinicalTrials.gov Identifier: NCT00005884 - Active, not recruiting
  prevention of skin cancer; basal cell carcinoma of the skin; squamous cell carcinoma of the skin
  
• Gemcitabine, Oxaliplatin in Combination with Bevacizumab in Patients with Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00142467 - Active, not recruiting
  Hepatocellular Carcinoma
  
• A Trial of Thymalfasin in Adult Patients with Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00082082 - Recruiting
  Carcinoma, Hepatocellular
  
• Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma
  ClinicalTrials.gov Identifier: NCT00176800 - Active, not recruiting
  Esophageal Carcinoma
  
• Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00002747 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity; ...
  
• Trial of Oral Karenitecin in Patients with Solid Tumors and Lung Cancer
  ClinicalTrials.gov Identifier: NCT00097903 - Recruiting
  Carcinoma; Carcinoma, Non-Small-Cell Lung
  
• Study of EKB-569 in Subjects with Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00067548 - Active, not recruiting
  Non-Small-Cell Lung Carcinoma; Carcinoma, Non-Small Cell Lung
  
• Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer
  ClinicalTrials.gov Identifier: NCT00004163 - Active, not recruiting
  salivary gland malignant mixed cell type tumor; salivary gland poorly differentiated carcinoma; stage III salivary gland cancer; ...
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
  ClinicalTrials.gov Identifier: NCT00003652 - Active, not recruiting
  stage II anal cancer; stage III anal cancer; squamous cell carcinoma of the anus; cloacogenic carcinoma of the anus; basaloid carcinoma of the anus
  
• Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00003127 - Active, not recruiting
  endometrial adenosquamous cell carcinoma; endometrial adenocarcinoma; stage IV endometrial cancer; endometrial clear cell carcinoma; ...
  
• Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00095186 - Active, not recruiting
  Carcinoma, Renal Cell
  
• Trial of BAY 43-9006 in Patients with Relapsed or Refractory Advanced Non-Small Cell Lung Carcinoma
  ClinicalTrials.gov Identifier: NCT00101413 - Active, not recruiting
  Non-small cell lung carcinoma
  
• Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer
  ClinicalTrials.gov Identifier: NCT00014118 - Active, not recruiting
  stage III squamous cell carcinoma of the oropharynx; stage IV squamous cell carcinoma of the oropharynx; ...
  
• Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads
  ClinicalTrials.gov Identifier: NCT00054951 - Active, not recruiting
  Hepatocellular Carcinoma
  
• A Randomized, Double-Blinded, Placebo-Controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00492752 - Active, not recruiting
  Cancer; Liver Cancer; Hepatocellular Carcinoma
  
• Combination Chemotherapy in Treating Patients With Merkel Cell Cancer
  ClinicalTrials.gov Identifier: NCT00003549 - Active, not recruiting
  neuroendocrine carcinoma of the skin
  
• Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers
  ClinicalTrials.gov Identifier: NCT00095563 - Active, not recruiting
  high-grade salivary gland carcinoma; low-grade salivary gland carcinoma; Salivary Gland Cancer
  
• Study to Evaluate Safety and Biological Activity of TroVax® Vaccine Given in Conjunction With IL-2 to Treat Locally Advanced or Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00325507 - Active, not recruiting
  Carcinoma, Renal Cell
  
• Everolimus Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib
  ClinicalTrials.gov Identifier: NCT00410124 - Active, not recruiting
  Metastatic Renal Cell Carcinoma
  
• Multimodality Treatment for Patients with Resectable NSCLC-BEACON Study: Bevacizumab+Chemotherapy for Operable NSCLC
  ClinicalTrials.gov Identifier: NCT00130780 - Recruiting
  Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell